HistoGeneX Holding SA
HistoGeneX Holding reported total assets of €66.4m at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jun 2026).
By total assets for 2025, HistoGeneX Holding ranks among the 1,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of HistoGeneX Holding shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HistoGeneX Holding's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jun 2026
- Year ended 31 Dec 2024filed on 25 Sep 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
HistoGeneX Holding's financial analysis
- Solvency99.2%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HistoGeneX Holding
HistoGeneX Holding's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0643.686.060
- VAT number
- BE0643686060
- Peppol
- Registered · 0208:0643686060 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Nov 2015
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 09 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
HistoGeneX Holding (SA) has been based in Antwerp since 2015, active in: activities of holding companies. For 2025, it reports a net profit of 24,715 € and equity of €65.9m; its revenue is not published. Its solvency stands at 99.2%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to HistoGeneX Holding
Companies in the same business, of comparable size and area, outside its group.
- Eurvest Activities of holding companies Nivelles · balance sheet €67.0m
- Anchr Holdings Europe Activities of holding companies Mechelen · balance sheet €43.3m
- Bossuyt Invest International Activities of holding companies Waregem · balance sheet €44.3m
- Invest Minguet Gestion Activities of holding companies Liège · balance sheet €77.7m
- United NRJ Activities of head offices Moorslede · balance sheet €53.6m
- V.D. Holding Activities of holding companies Mouscron · balance sheet €45.7m
- Aldeko Invest Business and other management consultancy activities Ghent · balance sheet €38.6m
- Cova-Invest Activities of holding companies Bruges · balance sheet €52.4m
Frequently asked questions about HistoGeneX Holding
What is the revenue of HistoGeneX Holding?
HistoGeneX Holding files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of HistoGeneX Holding?
In Belgium, the VAT number is the company number prefixed with BE: BE0643686060 for HistoGeneX Holding, if the company is VAT-registered. Its company number (CBE) is 0643.686.060.
Where is the registered office of HistoGeneX Holding?
According to the CBE register, the registered office of HistoGeneX Holding is in 2610 Antwerp.
What is the equity of HistoGeneX Holding?
At the close of the 2025 financial year, the equity of HistoGeneX Holding amounts to 65,856,608 €, a solvency of 99.2% of total assets.
Who manages HistoGeneX Holding?
The register lists 8 active mandates at HistoGeneX Holding. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is HistoGeneX Holding within its sector?
By total assets for 2025, HistoGeneX Holding ranks among the 1,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of HistoGeneX Holding
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →